Novel quinazoline-based EGFR kinase inhibitors: A review focussing on SAR and molecular docking studies (2015-2019)

P Bhatia, V Sharma, O Alam, A Manaithiya… - European Journal of …, 2020 - Elsevier
The over expression of EGFR has been recognized as the driver mechanism in the
occurrence and progression of carcinomas such as lung cancer, breast cancer, pancreatic …

An appraisal of anticancer activity with structure–activity relationship of quinazoline and quinazolinone analogues through EGFR and VEGFR inhibition: A review

K Haider, S Das, A Joseph… - Drug Development …, 2022 - Wiley Online Library
Cancer is one of the leading causes of death. Globally a huge number of deaths and new
incidences are reported annually. Heterocyclic compounds have been proved to be very …

[HTML][HTML] Structure–Activity Relationship Studies Based on Quinazoline Derivatives as EGFR Kinase Inhibitors (2017–Present)

A Șandor, I Ionuț, G Marc, I Oniga, D Eniu, O Oniga - Pharmaceuticals, 2023 - mdpi.com
The epidermal growth factor receptor (EGFR) plays a critical role in the tumorigenesis of
various forms of cancer. Targeting the mutant forms of EGFR has been identified as an …

[HTML][HTML] Novel benzimidazole derivatives as anti-cervical cancer agents of potential multi-targeting kinase inhibitory activity

EA Abd El-Meguid, EMM El-Deen, MA Nael… - Arabian Journal of …, 2020 - Elsevier
Abstract Multi-target EGFR, HER2, VEGFR-2 and PDGFR is an improved strategy for the
treatment of solid tumors. This work deals with synthesis of an array of new 6-benzoyl …

[PDF][PDF] 6, 7-disubstituted-4-anilinoquinazoline: design, synthesis and anticancer activity as a novel series of potent anticancer agents

FA Moghadam, M Evazalipour, H Kefayati… - Pharmaceutical …, 2020 - ps.tbzmed.ac.ir
Background: Epidermal Growth Factor Receptor (EGFR) and vascular endothelial growth
factor receptor (VEGFR) are responsible for several pathological conditions such as the …

EGFR-Targeted Quinazoline Clubbed Heterocycles as Anticancer Agents

V Panwar, K Mukherji, M Ghate, DK Jindal… - … Research: Drug Design …, 2022 - Springer
Cancer is a multifactorial chronic disease cohorted with different protein kinases. Epidermal
growth factor receptor (EGFR) is the ligand-gated ion channel receptor or protein kinase …

Synthesis, Crystal Structure and Anticancer Activity of Substituted Quinazoline Derivatives.

B Wang, Z Cai, X Shi, X Li, S Li… - Journal of the Chemical …, 2021 - search.ebscohost.com
News series of substituted quinazoline derivatives has been synthesized from 3, 4-dihydro-7-
methoxy-4-oxoquinazoline-6-yl acetate (1) by five-step procedures including chlorination …

Synthesis of Thiazole, Thiophene, pyran and pyridine derivatives derived from 3-phenyl-1H-pyrazol-5 (4H)-one with anti-proliferative, tyrosine kinase and PIM-1 …

RM Mohareb, IR Mikhail - Letters in Drug Design & Discovery, 2020 - ingentaconnect.com
Background: A wide range of pyrazole derivatives gained special attention due to their wide
range of pharmacological activities especially the therapeutic activities. Many …

Synthesis and Pharmacological Evaluation of Novel Quinazoline Derivatives as Potential EGFR Inhibitors for Breast Cancer.

DK Dwivedi, RK Agrawal - International Journal of …, 2023 - search.ebscohost.com
Background: Breast cancer is the highest mortality-causing disease among cancers in
women and it can be cured by early diagnosis as well as treatment. Epidermal growth factor …

Synthesis, Antimicrobial Activity and Molecular Docking Study of Novel N, 2-Diphenylquinazolin-4-amine Derivatives: Synthesis, Docking and Antimicrobial Activities …

N Seydbagian, E Dehghan-Ghahfarokhi… - Iranian Journal of …, 2023 - theses.sbmu.ac.ir
A new series of derivatives of N, 2-diphenylquinazolin-4-amine (3a-g) was synthesized
through nucleophilic substitution. The structures of compounds were characterized by FTIR …